|
3i Infotech
|
|
|
|
3i Infotech Limited has informed the Exchange about Grant of Stock Options under ESOS Scheme 2018 of the Company. Please refer attached intimation for further details.
|
|
|
Aarvi Encon
|
|
|
|
Aarvi Encon Limited has informed the Exchange about Board Meeting held on 26-May-2022 to consider financial statements for the period ended March 2022 and Other business matters
|
|
|
Acc
|
|
|
|
ICICI Securities Ltd & Deutsche Equities India Pvt Ltd ("Joint Managers to the Open Offer") has submitted to BSE a copy of Draft Letter of Offer to the Public Shareholders of ACC Ltd ("Target Company").
|
|
|
Ambuja Cement
|
|
|
|
ICICI Securities Ltd & Deutsche Equities India Pvt Ltd ("Joint Managers to the Open Offer") has submitted to BSE a copy of Draft Letter of Offer to the Public Shareholders of Ambuja Cements Ltd ("Target Company").
|
|
|
Anand Rathi Wealth
|
|
|
|
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, ("SEBI Listing Regulations"), we wish to inform you that Mr. Ashish Chauhan has tendered his resignation from the post of Company Secretary (Key Managerial Personnel) and Compliance Officer of the Company. The resignation has been noted and accepted by the Board of Directors. Accordingly, Mr. Ashish Chauhan shall cease to be Company Secretary and Compliance Officer of the Company with effect from 31st May, 2022. Ms. Jinal Trivedi is appointed as the Interim Compliance Officer of the Company with effect from 31st May 2022 during the interim period.
|
|
|
Arvee Laboratories
|
|
|
|
Arvee Laboratories (India) Limited has informed the Exchange about Board Meeting held on 26-May-2022 to consider financial statements for the period ended March 2022 and Other business matters.The Company has also appointed Mrs. Shalini Hitesh Jalan as Independent Director.
|
|
|
Ashok Alco Chem
|
|
|
|
Inter alia, approved: 1. Recommended dividend @5% i.e. Re. 0.50 per Equity Shares (face value of Re. 10/- each) of the Company for the year ended 31st March, 2022, subject to the approval of the shareholders at the ensuing Annual General Meeting ("AGM") of the Company. 2 Appointment of M/s R. A. Kuvadia & Co, Chartered Accountants, (Firm Registration No. 105487W), as Statutory Auditors of the Company for a term of 5 years from the conclusion of 30th Annual General Meeting till the conclusion of 35h AGM to be held in the year 2027,subject to the approval of shareholders at the ensuing AGM.
|
|
|
Ashoka Buildcon
|
|
|
|
inter alia, approved: 1.Appointment of M/s Patil Hiran Jajoo, Chartered Accountants, Nashik and M/s Suresh Surana & Co., Chartered Accountants Mumbai (Unit of RSM Astute) as Joint Internal Auditors for FY 2022-23; 2.Appointment of M/s S. R. Bhargave & Associates, Cost Accountants, as Cost Auditors for FY 2022-23; 3. The Board, based on the recommendations of the Audit Committee, has approved the re-appointment of M/s S R B C & CO. LLP, Chartered Accountants, (ICAI Firm Registration No.324982E/E300003) as Statutory Auditors of the Company for the second (2nd) term of five (5) years starting from conclusion of the 29th Annual General Meeting till conclusion of the 34th Annual General Meeting of the Company, subject to approval of the shareholders; 4.Fund raising proposal by way of through issue of Non-convertible debentures or any other debt securities, up to Rs.750 Crore, at an opportune time, subject to necessary approvals and compliance, if any
|
|
|
Asian Granito India
|
|
|
|
The Exchange has sought clarification from Asian Granito India Ltd on May 26, 2022, with reference to news appeared in https://www.moneycontrol.com dated May 26, 2022 quoting"Asian Granito shares fall 6% as tax sleuths raid company premises" The reply is awaited.
|
|
|
Aurobindo Pharma
|
|
|
|
We enclose a copy of the Press Release that is being issued by the Company in connection with USFDA approval received by Eugia Pharma Specialities Limited, a wholly owned subsidiary of the Company, for Pemetrexed for Injection.
|
|
|
|